Effects of Temperature on Albunex and FS069 Echocardiographic Contrast Agents: In Vitro Investigation Using Ultrasonic Irradiation
Authors:
- 1 January 1997
- journal article
- Published by Wiley in Echocardiography
- Vol. 14 (1) , 39-49
Abstract
The effects of temperature on the stability of two contrast agents, Albunex and perfluoropropane filled albumin microspheres (FS069), were investigated by studying the variations in their reflective properties, induced by high dose ultrasound irradiation at different temperatures. Diluted contrast agents were introduced into a 3.5-mL latex balloon, placed in a plastic water tank, and continuously irradiated over a period of 6 minutes using different power levels: 0, 20, 25, and 30 dB. The irradiation was interrupted for imaging every 30 seconds for 2 seconds. The protocol was carried out at three different temperatures: 8 degrees C, 22 degrees C, and 37 degrees C. For each temperature, the concentration of contrast solution was matched to produce approximately the same initial video intensity. Time variations in mean video intensity in the balloon cross section were studied. Contrast enhancement was found to be directly related to temperature. Under continuous ultrasonic irradiation, video intensity gradually decreased over time. This decrease was dependent on both transmitted power and temperature, and was more pronounced with Albunex when compared to FS069 (P < 0.05). Abruptly dropping temperature consistently resulted in rapid, irreversible disappearance of contrast induced by Albunex. Temperature affects the reflectivity and stability of diluted Albunex and FS069. To enhance the reproducibility of contrast enhancement achieved by these agents, their temperature should be carefully controlled.Keywords
This publication has 11 references indexed in Scilit:
- 955-58 Intracardiac Echocardiographic Quantification and Monitoring of Myocardial Perfusion Defects and Reperfusion with the Use of Intravenous Injection of FS069, a Transpulmonic Contrast AgentJACC, 1995
- 955-55 Reproducibility of Myocardial Opacification Using FS069, a New Intravenously Administered Ultrasound Contrast AgentJACC, 1995
- Effects of left ventricular pressure on sonicated albumin microbubbles: Evaluation using an isolated rabbit heart modelJACC, 1994
- Effect of Static Pressure on the Disappearance Rate of Specific Echocardiographic Contrast AgentsJournal of the American Society of Echocardiography, 1994
- Myocardial Contrast Enhancement After Intravenous Injection of Sonicated Albumin Microbubbles: A Transesophageal Echocardiography Dipyridamole StudyJournal of the American Society of Echocardiography, 1994
- Pitfalls in Quantitative Contrast Echocardiography: The Steps to Quantitation of PerfusionJournal of the American Society of Echocardiography, 1993
- Myocardial perfusion: Contrast echocardiography perspectivesThe American Journal of Cardiology, 1992
- Principles and recent developments in ultrasound contrast agentsUltrasonics, 1991
- Intravenous contrast echocardiography with use of sonicated albumin in humans: Systolic disappearance of left ventricular contrast after transpulmonary transmissionJACC, 1990
- The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography.Circulation Research, 1989